Check out the latest @olcina_lab publication - we describe a way to improve radiotherapy in tumours with immunosuppressive microenvironments
Many thanks to everyone who made this possible!
https://t.co/Cw9YkoPsX8
@The_MRC@CR_UK@acmedsci@NIH@OxfordCancer@OxfordOncology
Excited to share our latest research: MIC, a benzocoumarin molecule that enhances #longevity in #celegans by triggering #mitophagy. Our findings also show MIC's effectiveness in mammalian cells, indicating potential broader application. Full text here: https://t.co/hxBN3Arhcg
Read the article in the latest issue—
Galectin-1 Mediates Chronic STING Activation in Tumors to Promote #Metastasis through MDSC Recruitment, by @dnambiar_86, @Qle_stanford et al.
https://t.co/bvcKNxR2Ou
@StanfordMed
Very excited to share the latest preprint from the Lithgow Lab @BuckInstitute linking protein insolubility with Alzheimer's and the diseases of aging!
https://t.co/YvcrwUcolg
A thread of the story (1/11)
Could taurine be an anti-aging intervention in humans? Landmark study @ScienceMagazine shows restoring “youthful” levels of taurine hit several hallmarks of aging in worms, mice and monkeys. Buck researchers were involved in the work and talk about here: https://t.co/EUKpvVPyIw
I'm thrilled and delighted to be a part of this multi-collaborative research endeavor. Congratulations Vijay and all the authors involved! https://t.co/o9UL5KCqu4
About 10% of patients experience hyper-progression after immunotherapy. This very cool paper shows that it is the beloved CD8+ T cells that drive cancer hyperprogression via IFNγ! This alters B-catenin signaling. Great work!
https://t.co/UFOdXhREVN
IT'S OUT:Our paper on elective nodal irradiation mitigates local and systemic immunity generated by combination radiation + immunotherapy in head and neck tumors. Link: https://t.co/ssDN5N5fyc
@theliverdoc True,
In today's new paper I found this baba's advertisement with claim his Medicine can cure and prevent DM but we know it is a disorder which can not cure, as well as it cames under schedule J of D&C act which says list of disorder which can not cure
Very excited to share our latest collaborative study with the great #JennyTing showing that B cells can provide resistance to systemic STING agonist therapy, a superstar effort by @SiruiLi10 and #RahulMirlekar@UNC_Lineberger@UNCPancreas 👇https://t.co/PVRn708KzS